Left ofloxacin and Pidotimod compound preparation

Abstract

A compound medicine for exogenously killing pathogenic bacteria and endogenously improving immunity to treat bacterium-infections diseases is prepared from levoofloxacin and Piduomode.

Description

technical field [0001] The invention relates to a compound preparation of levofloxacin and pidotimod, which is used for treating bacterial infectious diseases. Background technique [0002] Infectious diseases are common problems encountered in clinical work, and about 80% of the infections in adults are caused by bacteria, involving outpatients and inpatients in various clinical departments. The most important clinical method for bacterial infection is the use of various antibiotics, making antibiotic products an important product in the field of pharmaceutical production. However, in recent years, as the problem of antibiotic resistance has become more and more serious, clinicians still face many problems such as complex, refractory infections and recurrent infections in the process of treating bacterial infectious diseases. At the same time, due to the increasing cycle and cost of developing new antibiotics, it is not realistic to find newer and stronger antibiotics in t...

AI Technical Summary

Problems solved by technology

However, in recent years, as the problem of antibiotic resistance has become more and more serious, clinicians still face many problems such as complex, refractory infections and recurrent infections in the process of treating bacterial infectious diseases

At the same time, due to the increasing cycle and cost of developing new antibiotics, it is not realistic to find newer and stronger antibiotics in the short term.

The progress of immunological research shows that such patients generally have the problem of low level of anti-infection immunity, and relying solely on exogenous antibacterial drugs is not enough to completely eliminate pathogenic bacteria, and it is easy to leave hidden dangers of drug resistance. Combination strategies to treat infections, especially the use of appropriate immunotherapeutic drugs, should be the best way to treat bacterial infections by improving the patient's own anti-infection immunity and mobilizing the body's endogenous anti-infection ability

Images